Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Product Development

First up for COVID-19: nearly 30 clinical readouts before end of April

Nearly 30 trials for COVID-19 could start to yield data in the next couple of months

March 14, 2020 3:21 AM UTC
Updated on Mar 14, 2020 at 4:20 AM UTC

Results from clinical trials for COVID-19 could start to roll in any day, with antimalarials coming through first, according to BioCentury’s analysis of study completion dates in public databases.

Almost 30 efficacy trials of repurposed agents for COVID-19 have completion dates that fall on or before April 30, according to ClinicalTrials.gov and the Chinese registry ChiCTR.org.cn...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article